All Posts

MedTech-News-updates-Eclipse-Medtronic-Aethlon-Cognoa-ObvioHealth
Eclipse, Medtronic, Aethlon, Cognoa, ObvioHealth, and others Continue to Veer MedTech Market Forward

Eclipse Launches MicroPen EVO™ Advanced Micro-needling Device On June 01, 2021, Eclipse, a leading aesthetic and medical manufacturer, received FDA clearance of their latest medical-grade micro-needling device, the MicroPen EVO. It had launched MicroPen EVO in Canada last year and now will make it availab...

Find More

Leading MedTech Companies 2021| Abbott | Medtronic | J&J | Boston Scientific |
Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation

The global coronavirus has affected almost every industry, and medical devices are no less affected. Even as the first quarter of 2021 has passed, the pandemic hasn’t. No industry has gone unharmed amidst the pandemic, and similarly, the healthcare industry is also witnessing the impact of the resurgence of the vir...

Find More

Spinal Stenosis Devices Market | Medical Devices Market | MedTech Market
Spinal Stenosis Devices Market Size to Balloon Up Owing to Increasing Prevalence & Geriatric Population, as well as Medical Advancements

Spinal stenosis refers to the condition characterized by the compression of nerve roots and narrowing of the spinal canal due to several pathologic factors, further leading to symptoms such as pain with a tingling sensation, numbness, and weakness. Spinal stenosis can involve the cervical, lumbar, or thoracic (rare...

Find More

latest-biotech-healthcare-pharma-news-updates-aelis-farma-alcyone-progentec-gsk-kozin
Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M

Aelis Farma pockets USD 30 Million upfront in cannabis use disorder deal with Indivior Indivior speculates that Aelis Farma has what it takes to bring cannabis use disorder therapy into the clinic with a USD 30 million upfront rights agreement. Aelis, clinical-stage French biotech zeroed in on brain disorders...

Find More

Migraine-Market Analysis
Migraine Market: How Pharma Companies are trying to Uncomplicate the Disease and Bring in Novel Therapies

Migraine is a medical condition characterized by recurrent headaches that can last from 4 to 72 hours and often results in a wide range of symptoms. It is mainly associated with a painful headache, however, the affected person may experience nausea, vomiting, disturbed vision, sensitivity to light, sound, and smell...

Find More

recent-pharma-news-updates-for-biogen-novo-nordisk-bluebird-bio
Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here   The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s disease under the accelerated approval pathway. The drug, marketed under the name Aduhelm, is the first that treats an un...

Find More

Pacemakers Pipeline Analysis
Continuous R&D Ramps Up the Pacemakers Pipeline Landscape, New Devices To Enter the Market Soon

Pacemaker is a device that is used to send small electrical impulses to the heart muscle to keep the heart rate regulated or to stimulate the lower chambers of the heart (ventricles). It can also be used to treat fainting spells (syncope), congestive heart failure, and hypertrophic cardiomyopathy. These are impl...

Find More

endoscopy-fluid-management-systems-market-trends-growth-forecast
What factors are guiding the Growth of Endoscopy Fluid Management Systems in the MedTech Market?

Endoscopy helps surgeons and clinicians to diagnose and perform surgery for various chronic and acute diseases in a proper and standard manner. During the procedure, both internal and external surfaces of endoscopes are exposed to body fluids. The need for an Endoscopy fluid management system arose due to the prese...

Find More

latest-medtech-news-and-updates-from-abbott-bd-procyrion-tricvalve
Latest Medtech Commercial, Regulatory and Clinical Updates For – Abbott, BD, CooperVision, Procyrion, TricValve, and others

Abbott receives CE Mark for Navitor™, the Latest-Generation Transcatheter Aortic Valve Implantation (TAVI) System for Aortic Stenosis treatment  On May 17, 2021, Abbott received CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor™. This marks the minimal...

Find More

key-companies-in-the-bone-cancer-treatment-market-
Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth

Over the past few decades, the incidence and prevalence of Cancer have grown significantly which has resulted in low quality of life and the survival rate. Today, cancer is the second leading cause of death globally, as per the WHO, in 2018, nearly 9.6 million people worldwide lost their life due to cancer. Cancer ...

Find More